Leuzy A - Search Results

1

Plasma neurofilament light associates with Alzheimer's disease metabolic decline in amyloid-positive individuals.

Benedet AL, Ashton NJ, Pascoal TA, Leuzy A, Mathotaarachchi S, Kang MS, Therriault J, Savard M, Chamoun M, Schöll M, Zimmer ER, Gauthier S, Labbe A, Zetterberg H, Blennow K, Neto PR. Benedet AL, et al. Among authors: leuzy a. Alzheimers Dement (Amst). 2019 Sep 27;11:679-689. doi: 10.1016/j.dadm.2019.08.002. eCollection 2019 Dec. Alzheimers Dement (Amst). 2019. PMID: 31673598 Free PMC article.

2

Diagnosis of prodromal Alzheimer's disease: do you really want to know?

Gauthier S, Leuzy A. Gauthier S, et al. Among authors: leuzy a. Can J Neurol Sci. 2010 Jan;37(1):2. doi: 10.1017/s0317167100009574. Can J Neurol Sci. 2010. PMID: 20169766 No abstract available.

3

Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease." A Canadian perspective.

Gauthier S, Patterson C, Gordon M, Soucy JP, Schubert F, Leuzy A. Gauthier S, et al. Among authors: leuzy a. Alzheimers Dement. 2011 May;7(3):330-2. doi: 10.1016/j.jalz.2011.03.006. Alzheimers Dement. 2011. PMID: 21575874

4

Ethical issues in Alzheimer's disease: an overview.

Leuzy A, Gauthier S. Leuzy A, et al. Expert Rev Neurother. 2012 May;12(5):557-67. doi: 10.1586/ern.12.38. Expert Rev Neurother. 2012. PMID: 22550984 Review.

5

Dissociation between brain amyloid deposition and metabolism in early mild cognitive impairment.

Wu L, Rowley J, Mohades S, Leuzy A, Dauar MT, Shin M, Fonov V, Jia J, Gauthier S, Rosa-Neto P; Alzheimer’s Disease Neuroimaging Initiative. Wu L, et al. Among authors: leuzy a. PLoS One. 2012;7(10):e47905. doi: 10.1371/journal.pone.0047905. Epub 2012 Oct 24. PLoS One. 2012. PMID: 23112868 Free PMC article. Clinical Trial.

6

Diagnosis and management of Alzheimer's disease: past, present and future ethical issues.

Gauthier S, Leuzy A, Racine E, Rosa-Neto P. Gauthier S, et al. Among authors: leuzy a. Prog Neurobiol. 2013 Nov;110:102-13. doi: 10.1016/j.pneurobio.2013.01.003. Epub 2013 Apr 8. Prog Neurobiol. 2013. PMID: 23578568 Review.

7

How can we improve transfer of outcomes from randomized clinical trials to clinical practice with disease-modifying drugs in Alzheimer's disease?

Gauthier S, Leuzy A, Rosa-Neto P. Gauthier S, et al. Among authors: leuzy a. Neurodegener Dis. 2014;13(2-3):197-9. doi: 10.1159/000353748. Epub 2013 Aug 7. Neurodegener Dis. 2014. PMID: 23942173 Review.

8

Imaging biomarkers for amyloid: a new generation of probes and what lies ahead.

Leuzy A, Zimmer ER, Bhat V, Rosa-Neto P, Gauthier S. Leuzy A, et al. Int Psychogeriatr. 2014 May;26(5):703-7. doi: 10.1017/S1041610214000118. Epub 2014 Feb 13. Int Psychogeriatr. 2014. PMID: 24524685 No abstract available.

9

In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals.

Zimmer ER, Leuzy A, Bhat V, Gauthier S, Rosa-Neto P. Zimmer ER, et al. Among authors: leuzy a. Transl Neurodegener. 2014 Mar 15;3(1):6. doi: 10.1186/2047-9158-3-6. Transl Neurodegener. 2014. PMID: 24628994 Free PMC article.

10

Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues.

Leuzy A, Zimmer ER, Heurling K, Rosa-Neto P, Gauthier S. Leuzy A, et al. Amyloid. 2014 Sep;21(3):143-8. doi: 10.3109/13506129.2014.926267. Epub 2014 Jun 11. Amyloid. 2014. PMID: 24919109 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters